1. Executive Summary
1.1. Global Neurovascular Thrombectomy Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
3.1. Global Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Stent Retriever
3.1.1.2. Aspiration Catheter
3.2. Global Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Neuro-Catheterization Labs
3.2.1.3. Specialized Neurosurgery Centers
3.3. Global Neurovascular Thrombectomy Devices Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
4.1. North America Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Stent Retriever
4.1.1.2. Aspiration Catheter
4.2. North America Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Neuro-Catheterization Labs
4.2.1.3. Specialized Neurosurgery Centers
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
5.1. Europe Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Stent Retriever
5.1.1.2. Aspiration Catheter
5.2. Europe Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Neuro-Catheterization Labs
5.2.1.3. Specialized Neurosurgery Centers
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.5. France Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.6. France Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.7. Italy Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
6.1. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Stent Retriever
6.1.1.2. Aspiration Catheter
6.2. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Neuro-Catheterization Labs
6.2.1.3. Specialized Neurosurgery Centers
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.2. China Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.7. India Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.8. India Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
7.1. Latin America Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Stent Retriever
7.1.1.2. Aspiration Catheter
7.2. Latin America Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Neuro-Catheterization Labs
7.2.1.3. Specialized Neurosurgery Centers
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
8.1. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Stent Retriever
8.1.1.2. Aspiration Catheter
8.2. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Neuro-Catheterization Labs
8.2.1.3. Specialized Neurosurgery Centers
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic Plc
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Stryker Corporation
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Teleflex Incorporated
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Terumo Corporation
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Johnson & Johnson Services, Inc.
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Penumbra Inc.
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Boston Scientific Corporation
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Edwards Lifesciences Corporation
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Acandis GmbH
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Argon Medical Inc
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations